Tilray Inc (NASDAQ: TLRY)'s stock is up another 12.5 percent in the past week, but Citron Research’s Andrew Left said he's still short the stock and Canadian marijuana companies will not be the winners from a potential U.S. marijuana legalization.
At the Reuters Global Investment Outlook Summit on Monday, Left said leading Canadian marijuana companies would likely get steamrolled by larger American competitors in the event of U.S. legalization given that there is no brand value or competitive moat in the U.S. cannabis business.
“When U.S. LPs (companies) go public in the next few years it will make these Canadian companies laughable,” Left said.
Why It’s Important
Tilray shares are now up 339 percent in the past three months, and the U.S.-listed Canadian cannabis company isn't alone:
- ETF MANAGERS TR/TIERRA XP LATIN AME (NYSE: MJ) is up 19.8 percent.
- Canopy Growth Corp (NYSE: CGC) is up 35.4 percent.
- Cronos Group Inc (NASDAQ: CRON) is up 37.5 percent.
- Aurora Cannabis Inc (NYSE: ACB) is up 49.9 percent.
- Aphria Inc (NYSE: APHA) is up 47.2 percent.
Canadian marijuana stocks have capitalized on investor enthusiasm following nationwide recreational cannabis legalization in Canada in October and state legalization measures approved by U.S. voters last week in Michigan and Missouri.
Left said he understands why investors are excited about the cannabis market but said Tilray is a dangerous way to play the trend. Right now, Left said Canopy Growth is the global market leader, although he has no position in the stock.
Left said the next potential bearish catalyst for Tilray will be its lockup expiration date on Jan. 15, 2019.
“What happens the day the lockup expires and the float doubles? What happens to the stock then?" Left said, according to Reuters.
What Jeff Sessions' Resignation Could Mean For Cannabis Stocks
What A Split Congress Means For The Stock Market
See more from Benzinga
- What Jeff Sessions' Resignation Could Mean For Cannabis Stocks
- Tariffs, Drug Prices, Legislative Gridlock: What Economists Are Watching Following The Midterm Election
- Here's What's At Stake For Your Investments In The 2018 Midterms
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.